Technology · Health & biomedicine / Regenerative & personalized medicine

Implantable nerve-stimulation devices (deep brain stimulation)

Implanted stimulators for advanced Parkinson's disease that replace medication-only treatment and cut the need for replacement surgery — in the commercial stage in China, with innovative products approved in 2022–2024.

Maturity 8/9 Risk: medium Medical devices & implants CN verified 2026-10-16 · 3 Sources

1 · What it gives

Implantable nerve-stimulation products replace conventional medication-only treatment for advanced Parkinson’s disease and reduce the need for secondary surgery to replace electrodes. They are at commercial scale in China, with various innovative products approved for marketing between 2022 and 2024.

2 · What it replaces 6

D1	Bio-based plasticizers — epoxidized soybean/linseed oil (ESBO), citrate esters (ATBC), isosorbide diesters, castor-oil derivatives — instead of ortho-phthalates (DEHP, DBP, BBP, DIBP) in PVC Replaces: Low-molecular-weight ortho-phthalate plasticizers in flexible PVC (flooring, cables, films, toys, medical tubing, food-contact gaskets)	CHEM
D1	Fermentation (stainless and single-use bioreactors, solid-state reactors) and downstream equipment (centrifuges, filtration, spray and fluid-bed drying, formulation) for local production of enzymes, microbial products and fermentation ingredients instead of chemical-synthesis plants and imports Replaces: Chemical-synthesis routes and imports for the products in FI-, FD-, I- and A-series articles (enzymes, organic acids, vitamins, microbial …	EAC
D3	Agricultural spraying drones instead of knapsack and manned aerial spraying Replaces: Manual knapsack spraying, tractor spraying in small or wet fields, and manned aircraft/helicopter spraying	EAC
D0	Bacteriophage therapy for bacterial disease in fish and shrimp farming instead of medicated-feed antibiotics Replaces: Antibiotics in medicated feed and bath treatments - oxytetracycline, florfenicol, oxolinic acid, enrofloxacin, sulfonamide-trimethoprim …	VET
D2	Bumblebee pollination instead of hormone sprays and manual vibration in greenhouse tomatoes Replaces: Fruit-setting hormone sprays (synthetic auxins such as 4-CPA / tomatotone) and labour-intensive manual flower vibration in greenhouse …	MACRO
D2	Copper (and nickel/cobalt) recovery from low-grade and secondary sulfide ores by heap and dump bioleaching + SX-EW — instead of concentration and smelting Replaces: Pyrometallurgical smelting of sulfide concentrates (SO2, arsenic, heavy-metal emissions) for low-grade ores that would otherwise be …	SERV

3 · How to implement 3 steps

1
Select the patient
Select advanced-stage patients for implantation.
2
Implant
Implant the stimulator and electrodes.
3
Programme and follow up
Programme the stimulation and follow the patient.

4 · Who delivers

Matched suppliers (matched automatically)

EGAVET	Egypt	Research / RTO	active
Abtec	India	Research / RTO	active
EcoFix Kenya Ltd (EFK)	Kenya	Producer	active
PT. Central Proteina Prima, Tbk	Indonesia	Producer	active
Aristogene Biosciences Pvt. Ltd.	India	Producer	active
EnviroWay BioScience Pvt Ltd	India	Services / consulting	active
NSL Sugars	India	Research / RTO	active
XIKE Enzymes	China	Research / RTO	active
Aleph Farms	Israel	Producer	active
BM GreenTech Berhad	Malaysia	Research / RTO	active
BioHAYAT	Turkey	Research / RTO	active
Biomason	United States	Producer	active

Leading companies and institutes (from the brief)

Beijing PINS Medical and Boston Scientific Neuromodulation are named as providers. Others are matched by the portal under Medical devices & implants.

5 · Rules & route to market

Route into Russia / EAEU: CHEM · Minpromtorg (registration) / Rospotrebnadzor (notification of new substances)
state registration ~10-15 working days after expert assessment; new substances need notification
Information, not legal advice — confirm the procedure for your product. (2026-10-06)

United States

The sources reviewed on 2026-10-16 identified no the US regulator or standard specific to this technology. Treat the route as case-by-case and ask for a check.

European Union

The sources reviewed on 2026-10-16 identified no the EU regulator or standard specific to this technology. Treat the route as case-by-case and ask for a check.

China

In China the NMPA regulates these devices under standards such as YY 0989.3-2023.

6 · Money: tenders & grants

Grant	Circular innovative advanced materials: facilitating the transition from design to markets (RIA) (Innovative … European Commission · EU	Feb 2, 2027 109 days
Grant	Boosting Innovative GEOINT - Science & Technology Broad Agency Announcement (BIG-ST BAA) National Geospatial-Intelligence Agency · United States	Dec 14, 2026 59 days
Grant	Doctoral focal award: UKRI venture doctorates: outline stage UKRI · United Kingdom	Oct 22, 2026 6 days
Grant	Enhancing ecodesign and circularity of construction products European Commission · EU	Sep 22, 2027 341 days
Grant	First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based … National Institutes of Health · United States	Oct 15, 2027 364 days

7 · Tech stack & innovations

The sources reviewed list no verified risks; surgical and device-failure risks should be assessed case by case.

Sources 3

English.nmpa.gov.cn — english.nmpa.gov.cn 2026-10-16
Chinastandards.org — chinastandards.org 2026-10-16
Nmpa.gov.cn — www.nmpa.gov.cn 2026-10-16